NIH-funded research R01 grant

Creating new tools to analyze RNA modifications in cells

Official title: Develop new bioinformatics infrastructures and computational tools for epitranscriptomics data

Funded at University of Chicago · NIH-11045681 · Data updated 2026-11-12

This study is all about creating easy-to-use tools that help scientists understand how tiny changes in RNA can affect gene activity, which is important for learning more about diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startMay 15, 2023
Project endFebruary 28, 2027
Funding year2025
Award (this year)$393,270
NIH project number5R01HG012927-03
Project IDNIH-11045681 on NIH RePORTER

Who could benefit from this research

Could help

Patients with conditions influenced by RNA modifications, such as certain cancers or genetic disorders, may benefit from this research.

Less likely to help

Patients with conditions unrelated to RNA biology or those not affected by RNA modifications may not receive any benefit from this research.

What this research studies

This research focuses on developing advanced bioinformatics tools to analyze dynamic RNA modifications, which play a crucial role in gene expression regulation. By utilizing cutting-edge sequencing technologies, the project aims to profile RNA modifications across different conditions and cell types. The researchers will create statistical methods for detecting these modifications at a very precise level and develop user-friendly software to help scientists integrate this data with genomic features. This work is essential for enhancing our understanding of RNA biology and its implications in various diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of diseases linked to RNA modifications.

How similar studies have gone: While the field of epitranscriptomics is relatively new, there have been promising developments in related areas, indicating potential for success with these innovative approaches.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Chen, Mengjie — University of Chicago
  • Study coordinator: Chen, Mengjie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.